THROMBOPHILIC RISK FACTORS IN PATIENTS WITH CRANIAL AND SPINAL DURAL ARTERIOVENOUS FISTULAE
Authors:
- Rüediger GerlachRGRüediger Gerlach
- Martina Boehm-WeigertMBMartina Boehm-Weigert
- Joachim BerkefeldJBJoachim Berkefeld
- Judith DuisJDJudith Duis
- Andreas RaabeARAndreas Raabe
- Volker SeifertVSVolker Seifert
- Gerhard MarquardtGMGerhard Marquardt
- 1 October 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 63 (4) , 693-699
Abstract
Numerous studies have reported the technical aspects and results of surgical and/or endovascular treatment of cranial dural arteriovenous fistulae (cDAVF) and spinal dural arteriovenous fistulae (sDAVF). Only a few of them have addressed the question of thrombophilic conditions, which may be relevant as pathogenetic factors or can increase the risk for venous thromboembolic events. Therefore, the objective of this study is to compare thrombophilic risk factors in patients with cDAVF and sDAVF with no history of trauma. A total of 43 patients (25 with cDAVF and 18 with sDAVF) were included in this study. Blood samples were analyzed for G20210A mutation of the prothrombin gene and factor V Leiden mutation. In all patients, prothrombin time, international normalized ratio, fibrinogen, antithrombin, protein C and S activity, von Willebrand factor antigen, ristocetin cofactor activity, D-dimer, coagulation factor VIII activity, and tissue factor pathway inhibitor were determined. Screening was performed for the occurrence of lupus antiphospholipid and cardiolipin antibodies. The prevalence of G20210A mutation of the prothrombin gene was significantly higher in patients with cDAVF (n = 6) compared with patients with sDAVF (n = 0; P < 0.05, Fisher's exact test). A factor V Leiden mutation was found in 3 patients with sDAVF and in 1 patient with cDAVF (P = 0.29, Fisher's exact test). No significant difference was found for other parameters, except for fibrinogen, but decreased protein C activity was more frequent in patients with cDAVF compared with patients with sDAVF (4 versus 1). Decreased protein S activity was encountered in 3 patients (2 with sDAVF and 1 with cDAVF). Cardiolipin antibodies were found in 2 patients with cDAVF but in none with sDAVF, whereas only 1 patient with sDAVF had lupus antiphospholipid antibodies. In both groups of patients with dural arteriovenous fistulae, genetic thrombophilic abnormalities occurred in a higher percentage than in the general population. The differences of the genetic abnormalities may be involved in different pathophysiological mechanism(s) in the development of these distinct neurovascular entities.Keywords
This publication has 43 references indexed in Scilit:
- Surgical disconnection of cortical venous reflux as a treatment for Borden type II dural arteriovenous fistulaeActa Neurochirurgica, 2007
- THROMBOPHILIC ABNORMALITIES AMONG PATIENTS WITH CRANIAL DURAL ARTERIOVENOUS FISTULASNeurosurgery, 2007
- Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosisJournal of Thrombosis and Haemostasis, 2004
- Spinal Dural Arteriovenous Fistulas Are Not Associated With Prothrombotic FactorsStroke, 2004
- Increased incidence of thrombophilic abnormalities in patients with cranial dural arteriovenous fistulaeNeurological Research, 2003
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- Epidemiology of Factor V Leiden: Clinical ImplicationsSeminars in Thrombosis and Hemostasis, 1998
- Coagulation Studies, Factor V Leiden, and Anticardiolipin Antibodies in 40 Cases of Cerebral Venous ThrombosisStroke, 1996
- Genesis of a dural arteriovenous malformation in a rat modelJournal of Neurosurgery, 1995
- Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage.Radiology, 1995